Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.
Kojiro OhbaKeisuke MonjiTakahiro OsawaKazutoshi YamanaYosuke YasudaHajime TanakaYuki NakagawaTamaki FukuyamaNobuaki MatsubaraHirotsugu UemuraHideki SakaiMasatoshi EtoPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)
JEWEL identified sex, age, ECOG PS, liver and bone metastases, CRP levels, WHO/ISUP grade, LDH, and albumin levels as key prognostic factors for OS after first-line TKI therapy for mRCC.